CLEVELAND, March 12, 2018 --
Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Bank of America Merrill Lynch Global Industrials & EU Autos Investor Conference in London, England on March 20, 2018 at 11:25 a.m. Greenwich Mean Time (7:25 a.m. Eastern time).
Parker's scheduled presenter is Tom Williams, Chairman and Chief Executive Officer. A live webcast of the presentation will be accessible on Parker's investor information website at www.phstock.com and will be archived on the site for one year.
Parker Hannifin is a Fortune 250 global leader in motion and control technologies. For 100 years the company has engineered the success of its customers in a wide range of diversified industrial and aerospace markets. Parker has increased its annual dividend per share paid to shareholders for 61 consecutive fiscal years, among the top five longest-running dividend-increase records in the S&P 500 index. Learn more at www.parker.com or @parkerhannifin.
###
Contact: Media – Aidan Gormley, Director, Global Communications and Branding 216/896-3258 [email protected] Financial Analysts – Robin J. Davenport, Vice President, Corporate Finance 216/896-2265 [email protected]


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 



